Skip to main content

Chris Bolten is a globally recognized IP attorney focusing on MedTech and technology fields, advising on over $35 Billion in MedTech acquisitions. Chris represents 55+ MedTech companies and VCs in the medical device and digital health industries–including those utilizing artificial intelligence (AI)–across the United States, Europe, and Israel. He has handled over 100 IP diligences for premiere venture capital firms and for MedTech companies. Chris served as IP counsel for the company or investors in the #1 and #2 MedTech acquisitions of private companies in 2024, the #1 overall MedTech acquisitions in 2022 and 2024, and the largest MedTech acquisition in the history of Israel, amongst many others. Having litigated dozens of patent cases in federal court across the United States for MedTech companies and other household name companies, Chris builds litigation-ready IP to facilitate investment, acquisition, and enforcement.

Chris handles matters involving technologies like structural heart devices, stents, shunts, prosthetic heart valves, catheters, robotics, AI, neurovascular, peripheral and cardiovascular, connected health, wearable devices, spine, surgery, orthopedics, interventions, electrophysiology, ophthalmology, women’s health, dental, neuromodulation, ablation, wound healing, diagnostics, drug delivery, microfluidics, software, cloud computing, networks for AI, and internet systems. His experience includes IP portfolio strategy, patent prosecution, FTO opinions, and litigation.

Concentrations

  • Patent portfolio management and strategic counseling
  • IP due diligence for venture capital firms and companies
  • MedTech—medical devices, digital health, artificial intelligence (AI)
  • Litigation and pre-litigation strategy

Competenze

Esperienze Professionali - Attività Accademiche

  • Represented Sofinnova Partners (Paris, France) in the investment of ShockWave Medical (subsequently acquired by J&J) on technology for treating heavily calcified arteries for Peripheral and Coronary Artery Disease (PAD and CAD).°
  • Represented Gyrus Capital (Geneva, Switzerland) in the investment of Neo Medical to accelerate the company’s global growth in spine surgery.
  • Represented Endeavour Vision (Geneva, Switzerland) in the investment of Vertiflex (subsequently acquired by Boston Scientific) on implants for lumbar spinal stenosis (LSS).°
  • Represented Bpifrance and Sofinnova Partners in investments of LimFlow (subsequently acquired by Inari Medical) on minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI).°
  • Represented Gyrus Capital in the purchase of the heart valve business from LivaNova.°
  • Represented Endeavour Vision in the investment of Gynesonics (subsequently acquired by Hologic), a women’s health company selling medical devices for treating uterine fibroids.°
  • Representing a Fortune 50 company involved in medical devices, including cardiovascular.
  • Representing a Fortune 500 company involved in cloud computing, networks for AI, content delivery networks (CDN), security, and managed services.
  • Representing Moon Surgical on robotic systems used to assist with surgery.
  • Represented ReCor Medical (acquired by Otsuka) on renal denervation for the treatment of hypertension.°
  • Represented Cardiologs (acquired by Philips) on machine learning and artificial intelligence software for analyzing electrocardiogram (ECG) signals from a patient’s heart.°
  • Represented Distalmotion on a tele-operated surgical robot for performing surgery.°
  • Represented AMF Medical (acquired by Tandem Diabetes Care) on wearable pumps for delivering insulin to treat diabetes.°
  • Patent litigation in California involving anti-malware and anti-virus computer security software.°
  • International Trade Commission (ITC) patent litigation on dental implants.°
  • Patent litigation in Texas on standard essential patents (SEPs) for optical transport networks (OTN).°
  • Patent and contract litigation in California involving pulse oximetry.°
  • Patent litigation in Colorado on SEPs for long term evolution (LTE) cellular technology.°
  • Patent litigation in California on SEPs for 802.11 (WiFi) and code-division multiple access (CDMA).°
  • Patent litigation in Delaware on graphical user interfaces (GUIs) for smartphones.°
  • Patent litigation in California involving specialized automotive parts for racing.°
  • Trade secret and patent litigation in California on tracking automotive driving activities.°

°The above representations were handled by Mr. Bolten prior to his joining Greenberg Traurig, LLP.

Riconoscimenti e Premi

  • Listed, Chambers USA Guide, Intellectual Property: Patent Prosecution, 2022-2024
  • Listed, The Legal 500 United States, 2017, 2020, and 2023
    • Recommended, Patent Prosecution, 2020 and 2023
    • “Next Generation Lawyer,” Patent Prosecution, 2017
  • Listed, Super Lawyers magazine, “San Diego Super Lawyers,” 2015-2022

Formazione

Formazione
  • Laurea magistrale in Giurisprudenza, magna cum laude, Arizona State University Sandra Day O'Connor College of Law
  • B.S., Mechanical Engineering, with honors, Michigan State University
Abilitazioni
  • California
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court for the Central District of California
  • U.S. District Court for the Northern District of California
  • U.S. District Court for the Southern District of California
  • U.S. District Court for the Eastern District of Texas
  • U.S. Patent and Trademark Office